WuXi AppTec has acquired Pharmapace, a US-based clinical research services company with expertise of providing high-quality biometrics services for all phases of clinical trials, regulatory submissions, and post-marketing support.
WuXi AppTec's newly expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including phase I GMP manufacturing.